Red dye No. 3 is now banned in the US -- but it'll take time to phase it out completely. In the meantime, the FDA just ...

The U.S. Food and Drug Administration has approved Verastem's combination therapy for patients with a rare type of ovarian ...

The PAM Health Rehabilitation of Tulsa held free mini screenings to show stroke survivors a new FDA-approved rehabilitation ...

Orchestra BioMed's AVIM earns FDA breakthrough designation, sparking investor optimism. Click here to read why OBIO stock is ...

Convenience store owners express concerns about implementation timeline and potential business disruption as the law requires removal of non-FDA approved vape products. The legislation will be ...

FDA will implement a secure generative AI system across all centers by June 30, aiming to streamline internal reviews and ...

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

The U.S. Food and Drug Administration on Wednesday approved Johnson & Johnson's drug to treat a type of muscle-weakening disorder, which is expected to bring in blockbuster revenues and drive growth.

A decision is expected in the fourth quarter of 2025.

The Trump administration argues that Kansas, Idaho, and Missouri have no standing sue the FDA over abortion pills in the Northern District of Texas.